Colgate Palmolive premium portfolio drives strong Q1 FY27 volume growth

Investment View and Recommendation

Prabhudas Lilladher retained its HOLD recommendation on Colgate Palmolive in its July 29, 2026 result update, following a positive volume surprise in Q1 FY27. The broker noted that near-term triggers remain limited. It raised its FY27E and FY28E EPS estimates by 1.3 per cent and 1.4 per cent, respectively, supported by sustained premium-portfolio traction, calibrated price increases to address raw-material volatility and cost-saving initiatives.

The target price was raised to Rs2,242 from Rs2,214, based on a valuation of 38 times March 2028 EPS.

Q1 FY27 Performance

Colgate Palmolive reported Q1 FY27 revenue of Rs16,033 million, up 11.8 per cent year on year and ahead of Prabhudas Lilladher's expectations. Volume growth was approximately 8.5 per cent, in the high-single-digit range, led by premium brands and sustained momentum in core brands. Urban demand remained stronger than rural demand.

EBITDA was above the broker's estimate, although the EBITDA margin contracted as advertising and promotion expenditure increased by 257 basis points to 15.7 per cent of sales. Adjusted PAT was also above Prabhudas Lilladher's estimate.

Premiumisation, Innovation and Margin Initiatives

The premium portfolio continued to grow faster than the mass portfolio. The report states that premiumisation has increased its contribution to the sales mix by 35 per cent over two years. New product launches in the sensorial portfolio include Max Fresh Berry Blast, while the Total Active Prevention foaming toothbrush was launched in toothpaste.

Colgate Palmolive took a low-single-digit price increase in May 2026. This is expected to partly offset higher input costs, although the full impact of the price increase and higher input costs is expected to be reflected from Q2 FY27. The company is expected to focus on margins through cost-saving measures and calibrated price increases amid the geopolitical environment, despite elevated advertising and promotion spending.

Growth Outlook and Revised Estimates

Prabhudas Lilladher forecasts approximately 5.5 per cent volume growth over FY26 to FY28, driven by a strengthening core toothpaste franchise, premiumisation through science-backed oral-care innovation and innovation across price points. The broker estimates a 9 per cent EPS CAGR over FY26 to FY28.

Key Risks

• A potential El Nino-related impact on rural demand could affect the near-term growth outlook.
• The full effect of input-cost inflation is expected from Q2 FY27 and could pressure margins.
• These pressures could constrain growth and margins despite premiumisation, price hikes and cost-saving initiatives.